NYMX News and Press, Nymox Pharmaceutical Corporation From 07/14/19

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) took a steep hit last week, crashing from 3,422.32 points on Monday’s (July 8) open to 3,315.46 points as of 1:32 p.m. EDT on Friday (July 12). A likely catalyst for the index’s crash was US President Donald Trump’s pled...

HASBROUCK HEIGHTS, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide an up-to-date investor communication presentation posted on the Nymox website today as the end of second quarter update for shareholders. The new company presenta...

Nymox Pharmaceutical ( NYMX ) has been accused of being an outright serial scam by well-known biopharma short expert Richard Pearson. This was from August 10, 2016, and he had this headline for his article - “Nymox: This Offshore 'Biotech' Promotion Will Go To Zero (Yes, Zero). ...

Thinly traded micro cap Nymox Pharmaceutical ( NYMX +6.4% ) is up on double normal volume, albeit on turnover of only 162K shares, on the heels of its meeting with the FDA to discuss part of the data package (CMC) for its marketing application for fexapotide triflutate for benign prostat...

HASBROUCK HEIGHTS, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that it has held its pre-New Drug Application (NDA) Chemistry Manufacturing and Controls (CMC) meeting with the US Food and Drug Administration (FDA) regarding its lea...

HASBROUCK HEIGHTS, N.J., March 21, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Nymox will hold a teleconference for shareholders on Monday, March 25 at 10:00 a.m. Eastern Daylight Time (EDT). Management will provide an update on the current status of the Co...

HASBROUCK HEIGHTS, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that Mark Staples PhD has joined Nymox as Vice President for Chemistry, Manufacturing, and Controls (CMC). Dr Staples is an expert in the field of biopharmaceuti...

HASBROUCK HEIGHTS, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the Company's Director of Quality and EU Qualified Person, for all of Nymox's Chemistry, Manufacturing a...

HASBROUCK HEIGHTS, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) will hold a teleconference for shareholders on March 25, 2019. Management will discuss the Company's current business progress with an update on its regulatory submission activities...

We at White Diamond Research like shorting medical device companies with an inefficient product or products. Last year, we exposed Transenterix ( TRXC ) and Viveve Systems ( VIVE ) as each has a medical device that is fundamentally flawed. Our next medical device stock short idea is Heli...